Dashboard
Manage Tickers

SLNOSOLENO THERAPEUTICS INC


$ 53.44 $ 0.63 (1.19 %)    

Wednesday, 18-Sep-2024 15:59:48 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 481.24 $ -0.31 (-0.06 %)
DIA $ 416.26 $ -1.07 (-0.26 %)
SPY $ 570.15 $ -0.30 (-0.05 %)
TLT $ 99.62 $ -1.25 (-1.24 %)
GLD $ 238.24 $ -0.87 (-0.36 %)
$ na
$ 53.42 x 100
-- x --
-- - --
$ 3.96 - $ 54.50
411,981
na
2.08B
$ 3.25
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

hc-wainwright--co-initiates-coverage-on-soleno-therapeutics-with-buy-rating-announces-price-target-of-70
HC Wainwright & Co. Initiates Coverage On ...
09/03/2024 11:49:46

HC Wainwright & Co. analyst Raghuram Selvaraju initiates coverage on Soleno Therapeutics (NASDAQ:SLNO) with a Buy rating...

hain-celestial-posts-upbeat-q4-earnings-joins-soleno-therapeutics-energizer-holdings-and-other-big-stocks-moving-higher-on-tuesday
Hain Celestial Posts Upbeat Q4 Earnings, J...
08/27/2024 14:38:00

soleno-therapeutics-announces-fda-acceptance-for-filing-and-priority-review-of-its-nda-for-dccr-extended-release-tablets-for-prader-willi-syndrome
Soleno Therapeutics Announces FDA Acceptan...
08/27/2024 12:12:32

oppenheimer-maintains-outperform-on-soleno-therapeutics-raises-price-target-to-65
Oppenheimer Maintains Outperform on Soleno...
08/12/2024 12:06:30

Oppenheimer analyst Leland Gershell maintains Soleno Therapeutics (NASDAQ:SLNO) with a Outperform and raises the price targe...

soleno-therapeutics-q2-eps-057-beats-063-estimate
Soleno Therapeutics Q2 EPS $(0.57) Beats $...
08/07/2024 20:34:20

Soleno Therapeutics (NASDAQ:SLNO) reported quarterly losses of $(0.57) per share which beat the analyst consensus estimate of $...

cantor-fitzgerald-reiterates-overweight-on-soleno-therapeutics-maintains-67-price-target
Cantor Fitzgerald Reiterates Overweight on...
07/31/2024 15:54:35

Cantor Fitzgerald analyst Kristen Kluska reiterates Soleno Therapeutics (NASDAQ:SLNO) with a Overweight and maintains $67 pr...

soleno-therapeutics-submits-nda-to-the-us-fda-for-dccr-diazoxide-choline-extended-release-tablets-for-the-treatment-of-prader-willi-syndrome
Soleno Therapeutics Submits NDA To The U.S...
06/28/2024 12:02:36

Soleno Therapeutics, Inc. ("Soleno") (NASDAQ:SLNO), a clinical-stage biopharmaceutical company developing novel therape...

soleno-therapeutics-set-to-join-russell-3000-index-effective-at-the-open-of-us-equity-markets-on-monday-july-1-2024
Soleno Therapeutics Set To Join Russell 30...
06/04/2024 12:26:17

Soleno Therapeutics, Inc. ("Soleno") (NASDAQ:SLNO), a clinical-stage biopharmaceutical company developing novel therape...

nvidia-is-up-186-from-a-year-ago-yet-these-7-stocks-have-more-than-doubled-their-returns-over-the-ai-chipmaker
Nvidia Is Up 186% From A Year Ago, Yet The...
05/29/2024 21:56:11

NVIDIA Corp. (NASDAQ:NVDA) has been the standout tech stock of the past year, leading the Nasdaq 100 index in the performance r...

soleno-therapeutics-announces-oral-presentation-featuring-dccr-extended-release-tablets-in-prader-willi-syndrome-at-endo-2024
Soleno Therapeutics Announces Oral Present...
05/22/2024 20:23:36

Soleno Therapeutics, Inc. ("Soleno") (NASDAQ:SLNO), a clinical-stage biopharmaceutical company developing novel therape...

oppenheimer-maintains-outperform-on-soleno-therapeutics-lowers-price-target-to-59
Oppenheimer Maintains Outperform on Soleno...
05/13/2024 12:36:24

Oppenheimer analyst Leland Gershell maintains Soleno Therapeutics (NASDAQ:SLNO) with a Outperform and lowers the price targe...

baird-initiates-coverage-on-soleno-therapeutics-with-outperform-rating-announces-price-target-of-72
Baird Initiates Coverage On Soleno Therape...
05/10/2024 09:19:10

Baird analyst Brian Skorney initiates coverage on Soleno Therapeutics (NASDAQ:SLNO) with a Outperform rating and announces P...

soleno-therapeutics-q1-2024-adj-eps-059-misses-037-estimate
Soleno Therapeutics Q1 2024 Adj EPS $(0.59...
05/09/2024 21:19:42

Soleno Therapeutics (NASDAQ:SLNO) reported quarterly losses of $(0.59) per share which missed the analyst consensus estimate of...

reported-earlier-soleno-therapeutics-prices-138m-public-offering-of-3m-common-stock-at-46share
Reported Earlier, Soleno Therapeutics Pric...
05/03/2024 06:07:50

Soleno has also granted the underwriters a 30-day option to purchase up to 450,000 shares of common stock at the public offerin...

soleno-therapeutics-announces-proposed-public-offering-of-common-stock-no-size-or-amount-disclosed
Soleno Therapeutics Announces Proposed Pub...
05/02/2024 20:41:22

Soleno Therapeutics, Inc. (NASDAQ:SLNO), ("Soleno" or the "Company"), a clinical-stage biopharmaceutical compan...

soleno-therapeutics-announces-peer-reviewed-publication-of-data-comparing-dccr-treatment-to-the-natural-history-of-prader-willi-syndrome
Soleno Therapeutics Announces Peer-Reviewe...
04/30/2024 12:15:19

Soleno Therapeutics, Inc. (Soleno) (NASDAQ:SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for ...

us-stocks-kick-off-the-week-in-the-green-tesla-rockets-on-chinas-fsd-approval-yen-rallies-whats-driving-markets-monday
US Stocks Kick Off The Week In The Green, ...
04/29/2024 18:14:53

U.S. stocks kicked off the week on a positive note, with all major averages edging higher in anticipation of significant events...

Core News & Articles
Why Clever Leaves Holdings Shares Are Trad...
04/29/2024 17:04:01

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
04/29/2024 16:31:20

tesla-deciphera-pharmaceuticals-heartland-financial-and-other-big-stocks-moving-higher-on-monday
Tesla, Deciphera Pharmaceuticals, Heartlan...
04/29/2024 14:47:40

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION